The major components of this program include comprehensive research training under supervision of committed mentors with diverse scientific expertise, incorporation of multidisciplinary approaches to biomedical investigation, well-equipped research environment with aces to state of the art technologies, protection from distracting responsibilities, and formal didactic instruction and enrichment activities. (A) Research Areas and Disciplines: A major strength of this training program is its multidisciplinary nature. This provides ample opportunities of training across disciplines, permitting novel approaches to be applied to complex biomedical problems. Training is offered in cell and molecular biology, structural biology, photobiology, stem cell biology, genetics, genomics, metabolomics and proteomics, autoimmunity and transplantation biology, and in translational research. These disciplines are applied to nine research themes that are relevant to diseases such as diabetes, hypertension, nephritis, vasculitis and polycystic kidney disease. For those trainees opting for clinical research, enrollment in formal instructional courses in the relevant quantitative sciences is mandated. All research trainees are required to complete a revised three- component program in the responsible conduct of research. (B) Level of Training, Background and Numbers of Trainees. In this renewal, we request eight postdoctoral positions, offered to MDs, MD-PhDs or PhDs on an annual basis. In addition, we request support for a one new predoctoral position each year to be offered to an under-represented minority student completing an undergraduate degree or enrolled in graduate or medical school. We also request tuition support for formal instructional courses in the basic sciences required of MDs with no previous training in bench research but who are committed to a basic research track. (C) Training Facilities. Research training is conducted in the laboratories of the research mentors, a collaborative group of established investigators with strong training records and scientific achievements in diverse scientific disciplines. The laboratories collectively occupy 277,700 sq. ft of dedicated research space located mainly at the Massachusetts General Hospital.

Public Health Relevance

The overall objective of the Nephrology Training Program at the Massachusetts General Hospital is to provide our trainees with a strong foundation in basic and translational research, using state of the art technologies to address complex biomedical problems pertaining to the renovascular system. Initially focused on providing experience in molecular and cell biology, the scope of the program is being expanded to also include training in new emerging fields and across scientific disciplines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007540-28
Application #
8509673
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Rys-Sikora, Krystyna E
Project Start
1986-07-01
Project End
2016-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
28
Fiscal Year
2013
Total Cost
$418,847
Indirect Cost
$32,228
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Poyan Mehr, Ali; Tran, Mei T; Ralto, Kenneth M et al. (2018) De novo NAD+ biosynthetic impairment in acute kidney injury in humans. Nat Med 24:1351-1359
Lim, Kenneth; Hamano, Takayuki; Thadhani, Ravi (2018) Vitamin D and Calcimimetics in Cardiovascular Disease. Semin Nephrol 38:251-266
Nguyen, Hai Dang; Leong, Wan Yee; Li, Weiling et al. (2018) Spliceosome Mutations Induce R Loop-Associated Sensitivity to ATR Inhibition in Myelodysplastic Syndromes. Cancer Res 78:5363-5374
Pang, Paul; Abbott, Molly; Abdi, Malyun et al. (2018) Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function. Nephrol Dial Transplant 33:923-934
Kabeche, Lilian; Nguyen, Hai Dang; Buisson, RĂ©mi et al. (2018) A mitosis-specific and R loop-driven ATR pathway promotes faithful chromosome segregation. Science 359:108-114
Cortazar, Frank B; Leaf, David E; Owens, Charles T et al. (2017) Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series. BMC Nephrol 18:44
Cortazar, Frank B; Pendergraft 3rd, William F; Wenger, Julia et al. (2017) Effect of Continuous B Cell Depletion With Rituximab on Pathogenic Autoantibodies and Total IgG Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol 69:1045-1053
Olabisi, Opeyemi A; Heneghan, John F (2017) APOL1 Nephrotoxicity: What Does Ion Transport Have to Do With It? Semin Nephrol 37:546-551
Tangren, Jessica Sheehan; Powe, Camille E; Ankers, Elizabeth et al. (2017) Pregnancy Outcomes after Clinical Recovery from AKI. J Am Soc Nephrol 28:1566-1574
Dehnadi, Abbas; Benedict Cosimi, A; Neal Smith, Rex et al. (2017) Prophylactic orthosteric inhibition of leukocyte integrin CD11b/CD18 prevents long-term fibrotic kidney failure in cynomolgus monkeys. Nat Commun 8:13899

Showing the most recent 10 out of 78 publications